Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

Obesity pipeline

What is next, and who is running it?

Programs by company or class, across phase, filing, approval, and a stop.

Phase 1 on
ClassNone selected
MechanismNone selected

Phase 1 included.

Clear filters

94 of 94 programs on this matrix

Phase 1Phase 2Phase 3FiledApprovedDiscontinuedStage n/r
GLP-1 RA17 programs
Dapiglutide

Phase 2

once weekly, injection

GLP-1 RA · Zealand Pharma

Bofanglutide

Registry, Jun 30, 2027

every 4 weeks, injection

GLP-1 RA · Gan & Lee Pharmaceuticals

Dulaglutide

Phase 3

once weekly, injection

GLP-1 RA · Company n/r

Ecnoglutide

Registry, Jan 5, 2027

once weekly, oral and injection

GLP-1 RA · Hangzhou Sciwind Biosciences Co

Efsubaglutide Alfa

Registry, Nov 30, 2026

once weekly, injection

GLP-1 RA · Shanghai Yinnuo Pharmaceutical Technology Co

HDM1002

Phase 3

once daily, oral

GLP-1 RA · Huadong Medicine

Mazdutide

Registry, Dec 31, 2026

once weekly, oral and injection

GLP-1 RA · Innovent

TG103

Phase 3

once weekly, injection

GLP-1 RA · CSPC Baike (Shandong) Biopharmaceutical Co

Supaglutide

Phase 2/3

weekly, oral and injection

GLP-1 RA · Shanghai Yinnuo Pharmaceutical Technology Co.

Beinaglutide

Stage n/r

once weekly, injection

GLP-1 RA · Company n/r

GLP-1/GIP7 programs
BGM0504

Registry, Feb 28, 2027

once weekly, oral and injection

GLP-1/GIP · BrightGene Bio-Medical Technology Co

CT-388

Registry, Nov 12, 2027

once weekly, injection

GLP-1/GIP · Roche

HDM1005

Registry, Dec 2026

once weekly, injection

GLP-1/GIP · Huadong Medicine

Ribupatide

Registry, Oct 31, 2027

once weekly, oral and injection

GLP-1/GIP · Fujian Shengdi Pharmaceutical Co

GLP-1/glucagon4 programs
Survodutide

Registry, Dec 8, 2026

once weekly, subcutaneous

GLP-1/glucagon · Boehringer Ingelheim

GIP/GLP-1/glucagon2 programs
UBT251

Registry, Jan 14, 2027

once weekly, oral and injection

GIP/GLP-1/glucagon · The United Bio-Technology (Hengqin) Co

Amylin combo1 program
Oral small molecule7 programs
TERN-601

Phase 2

once daily

Oral small molecule · Terns, Inc

Aleniglipron

Phase 3

once daily, oral

Oral small molecule · Gasherbrum Bio, Inc

Safiglipron

Phase 3

oral

Oral small molecule · Shandong Suncadia Medicine Co

VCT220

Phase 3

once daily, oral

Oral small molecule · Vincentage Pharma Co

GLP-1 conjugate1 program
Amylin6 programs
ACCG-2671

Phase 1/2

oral

Amylin · Aconcagua Bio, Inc

Myostatin/activin3 programs
MC4R1 program
Setmelanotide

Registry, Mar 13, 2027

once daily, injection

MC4R · Rhythm

CB12 programs
Monlunabant

Phase 2

once daily, oral

CB1 · Inversago Pharma

Lipase inhibitor1 program
Orlistat

Approved

once monthly, oral

Lipase inhibitor · Empros Pharma AB

Opioid and antidepressant1 program
Sympathomimetic combo1 program
Monoamine reuptake2 programs
Tesofensine

Phase 2

daily

Monoamine reuptake · NeuroSearch

Sibutramine

Phase 3

once daily, oral

Monoamine reuptake · Abbott

SARM1 program
Enobosarm

Phase 2

weekly, oral and injection

SARM · Veru Inc

Class not reported34 programs
CT-996

Phase 1

oral

Class not reported · Carmot Australia First Pty Ltd

DA-1726

Registry, Nov 9, 2026

injection

Class not reported · NeuroBo Pharmaceuticals Inc

HM15211

Phase 1

injection

Class not reported · Hanmi

Cetilistat

Phase 1

Dosing n/r

Class not reported · Alizyme

CRB-913

Phase 1

Dosing n/r

Class not reported · Corbus Pharmaceuticals

Nimacimab

Registry, Nov 20, 2026

injection

Class not reported · Skye Bioscience

Visepegenatide

Phase 1/2

once weekly, injection

Class not reported · PegBio Co

VRB-101

Phase 2

weekly, oral

Class not reported · Verdiva Bio Dev Limited

CT-868

Phase 2

once daily, injection

Class not reported · Carmot Therapeutics, Inc

LB54640

Phase 2

daily, oral

Class not reported · Rhythm

Taldefgrobep

Phase 2

once weekly, injection

Class not reported · Biohaven Therapeutics

Velneperit

Phase 2

once daily, oral

Class not reported · Shionogi

ASC30

Phase 3

once daily, oral and injection

Class not reported · Ascletis Pharma (China) Co

HDM1702

Phase 3

once weekly, injection

Class not reported · Huadong Medicine

Loxenatide

Phase 2/3

injection

Class not reported · Company n/r

RAY1225

Phase 3

once weekly, oral and injection

Class not reported · Guangdong Raynovent Biotech Co

Albiglutide

Phase 3

once weekly, oral and injection

Class not reported · GSK

Noiiglutide

Phase 3

once daily, oral and injection

Class not reported · Hengrui

MetAP2 inhibitor1 program
Beloranib

Phase 3

weekly, injection

MetAP2 inhibitor · Zafgen

Serotonin agonist1 program
Small molecule1 program
MDR-001

Phase 3

oral

Small molecule · MindRank AI Ltd